News | Cardiac Rehabilitation | May 02, 2022

COVID-19 Vaccine Technique Shows Promise for Heart Disease

This preliminary study was conducted to determine whether mRNA could be successfully delivered to the heart muscle in lipid nanoparticles.

3D illustration of an mRNA strand

Image: Getty Images


May 2, 2022 – A method for delivering genetic material to the body is being tested as a way to repair damaged heart muscle after a heart attack. The ground-breaking research was presented at Frontiers in CardioVascular Biomedicine 2022, a scientific congress of the European Society of Cardiology (ESC).

The COVID-19 messenger RNA (mRNA) vaccines use lipid nanoparticles (tiny fat droplets) to deliver mRNA to the body’s cells. This mRNA instructs the cells to manufacture a dummy spike protein on their surface to mimic the protein on the virus causing COVID-19. The body then mounts an immune response by creating antibodies which can be used if the individual becomes infected with the virus.

A similar method for mRNA delivery was used in the current study. However, instead of aiming for an immune response, the researchers’ ultimate goal is to instruct the heart’s cells to repair themselves after a heart attack.

This preliminary study was conducted to determine whether mRNA could be successfully delivered to the heart muscle in lipid nanoparticles. The researchers injected different formulations into the left ventricular wall of mouse hearts during open chest surgery under general anaesthesia. Twenty-four hours after administration, the mice were sacrificed and the location of mRNA translation was examined.

The researchers found that mRNA successfully reached the heart cells 24 hours after injection. However, despite injection into the heart, the highest levels of mRNA translation were found in cells of the liver and spleen.

Study author Dr. Clara Labonia of the University Medical Center Utrecht, the Netherlands said: “High expression was expected in the liver, since it metabolises the lipid nanoparticles. Nonetheless, it was encouraging to see that there was mRNA translation in the heart tissue which means that lipid nanoparticles could work as delivery systems for mRNA therapy.”

She concluded: “The next step of this research is to test more formulations and choose the one which most efficiently targets the heart tissue. We will then assess whether delivery of mRNA to mice with ischaemic hearts (resembling a heart attack) has any therapeutic effect.”

 

Related Content

News | ESC

June 1, 2022 — Eating low glycaemic index foods promotes a healthier body shape in patients with coronary artery disease ...

Home June 01, 2022
Home
News | ESC

May 9, 2022 — Heart failure presents differently in women and men – discover the latest evidence and its impact on ...

Home May 09, 2022
Home
News | ESC

March 31, 2022 — The annual congress of the European Heart Rhythm Association (EHRA), a branch of the ESC, will be held ...

Home March 31, 2022
Home
News | ESC

January 3, 2022 — The following is a list of the 2021 news stories from the European Society of Cardiology (ESC) ...

Home January 03, 2022
Home
News | ESC | By Dave Fornell, DAIC Editor

October 4, 2021 — Here are links to all the late-breaking cardiology studies presented in Hot-Line sessions at the 2021 ...

Home October 04, 2021
Home
News | ESC

The European Society of Cardiology (ESC) will host several Hot Lines sessions that will include some of the latest ...

Home July 21, 2020
Home
News | ESC

May 6, 2020 — The European Society of Cardiology (ESC), one of the world's largest cardiovascular conferences, is ...

Home May 06, 2020
Home
Feature | ESC

September 9, 2019 — More than 33,000 health professionals gathered over five days to attend the 2019 European Society of ...

Home September 09, 2019
Home
News | ESC

September 12, 2017 — Very aggressive reduction of LDL-cholesterol to ultra-low levels was associated with progressively ...

Home September 12, 2017
Home
News | ESC

September 12, 2017 — The IL-1β inhibitor canakinumab lowers the risk of cardiovascular disease and lung cancer risk by ...

Home September 12, 2017
Home
Subscribe Now